pancreatitis on semaglutide risk of with What are the risks associated Wegovy ( semaglutide)? Acute pancreatitis due to different – glp 1 contraindications pancreatitis semaglutide

Warning signs include: Dizziness upon standing Decreased urination or dark urine Dry mouth and increased thirst Muscle weakness or cramping Other Concerning Symptoms Immediate medical attention is warranted if fatigue occurs with: Severe abdominal pain (may indicate pancreatitis) Right upper quadrant pain, fever, or yellowing of skin/eyes (signs of gallbladder disease) Persistent vomiting preventing fluid intake Visual changes or severe headache (especially in patients with diabetes and retinopathy) Chest pain or shortness of breath Signs of allergic reaction (rash, swelling, difficulty breathing) The American Diabetes Association Standards of Care recommend regular monitoring of patients on GLP-1 receptor agonists, including assessment of tolerability, glycemic control, weight changes, and overall well-being

C.GoodmanS

Dose adjustments are based on individual response and tolerability

RAND, a not-for-profit and bipartisan research group, conducted the poll

Perhaps more impressive: 32% of people on Mounjaro lost at least 25% of their body weight compared to only 16% on Wegovy

Lastly, even though we provided dietary and exercise counseling to all participants, energy intake and physical activity were not measured, which may be a confounding factor of interindividual variability in weight loss between groups